GRAL GRAIL, Inc. - Common Stock

NASDAQ · Biotechnology · Voir sur SEC EDGAR ↗
$72,31
Prix · Aoû 18, 2026
Données fondamentales au Aoû 6, 2026

À propos de GRAIL, Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.

Lire la suite

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.

In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.

Activities

Illumina's own research showed that repeatedly sequencing DNA in the bloodstream made it possible to detect floating bits of DNA from cancer cells more accurately. It initially aimed to recruit greater than 100,000 people into its clinical trials in order to accumulate the sizeable data required to detect and interpret cancer biomarkers.

Galleri test

As of November 2020 Galleri investigated three multi-cancer screening tests.

In June 2021 Galleri launched their liquid biopsy or multi-cancer early detection test (MCED), which Grail called the Galleri test. Grail promoted the test as a "groundbreaking and potentially life-saving advance", although the results of early trials were poor. A subsequent large-scale NHS England trial was described as overhyped and unethical. As of 2024, Grail was facing discontent and legal action from investors.

In June 2025, an article in the New Yorker discussed an interview of their medicine and science writer regarding the test and its recent history with a focus on its potential for adaptation as research continues in its product development through clinical investigations.

On 17 October 2025, BBC news carried positive coverage of test results just presented at the European Society for Medical Oncology. However, as of October 20, 2025 the results of the PATHFINDER 2 study have yet to be peer reviewed or published. Eric Topol reported a sensitivity of only 40% these false negatives failed to discover cancer that emerged during the 12-month follow-up.

Company history

Grail began as a San Francisco biotechnology and pharmaceutical startup company in 2015, the parent company being Illumina of San Diego, which produces most of the DNA sequencing machines that scientists use to study human biology and diagnose rare genetic diseases. Richard Klausner, then chief medical officer at Illumina and former director of the National Cancer Institute, advocated for the new business. According to the San Francisco Business Times, he correctly predicted how DNA sequencing technology would make it possible to detect evidence of a tumor from a blood sample. He also joined Grail's board of directors. According to Forbes in 2017, 20% of Grail's profits are kept by Illumina.

In September 2020, Illumina announced an agreement to purchase Grail outright for $7.1 billion.

On November 27, 2020, Grail announced a commercial partnership with the National Health Service (England) (NHS), to trial the Galleri test, reporting in 2026.

In March 2021, the Federal Trade Commission (FTC) sued to block the vertical merger. In September 2022, an administrative judge ruled against the FTC's position on antitrust grounds.

In June 2023, Grail disclosed that letters were mailed to 408 patients incorrectly informing them that they may have cancer. The company blamed the incident on PWNHealth, saying that it was due to a software configuration issue, not due to incorrect Galleri test results.

In October 2023, the European Commission ordered Grail to be divested from Illumina within the next twelve months. The European Commission (EC) has since approved Illumina's divestment plan for separating from Grail. Illumina has set a goal of finalizing the divestment terms by the end of the second quarter of 2024. In April 2024, the EC approved Illumina's plan, allowing Illumina to explore either a trade sale or a capital markets transaction (spin-off) to divest Grail. In May 2024, Illumina publicly filed a Form 10 registration statement with the U.S. SEC, a necessary step for a potential capital markets separation of Grail. If a capital markets transaction occurs, Illumina must capitalize Grail with around $1 billion to fund 2.5 years of operations per the EC's divestment plan. The spinoff was completed in June 2024, with Grail trading on the Nasdaq with ticker symbol GRAL and Illumina retaining a 14.5% share of Grail.

Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗

Wikidata ↗

GRAL Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines

Prix
$72.31
Capitalisation Boursière
$2.97T
P/E (TTM)
-6638.1
BPA (TTM)
$-11.11
Revenus (TTM)
$147M
Rendement div.
ROE
-16.7%
Dette/Capitaux propres
Fourchette 52 semaines
$30 – $119

GRAL Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue

Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA

Revenus et bénéfice net $147M
4-point trend, +164.9%
2023-01-01 2025-12-31
BPA $-11.11
4-point trend, +93.6%
2023-01-01 2025-12-31
Flux de trésorerie libre $-300M
2-point trend, +48.5%
2024-12-31 2025-12-31
Marges -277.5%

Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?

Métrique
Tendance sur 5 ans
GRAL
Médiane des pairs
P/E (TTM)
2-point trend, -2642.6%
-6638.1
P/S (TTM)
2-point trend, +386.9%
20210.5
18.3
P/B
2-point trend, +454.0%
1153.8
3.3
Price / FCF (Cours / FCF)
2-point trend, -1007.9%
-9917.5

Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC

Métrique
Tendance sur 5 ans
GRAL
Médiane des pairs
Operating Margin (Marge d'exploitation)
2-point trend, +78.1%
-382.0%
Net Profit Margin (Marge nette)
2-point trend, +82.8%
-277.5%
-180.4%
ROA
2-point trend, +76.5%
-13.8%
-36.2%
ROE
2-point trend, +79.0%
-16.7%
-43.7%
ROIC
2-point trend, +79.7%
-16.7%

Santé financière Dette, liquidité, solvabilité — solidité du bilan

Métrique
Tendance sur 5 ans
GRAL
Médiane des pairs
Current Ratio (Ratio de liquidité)
2-point trend, +12.3%
12.0
9.7
Quick Ratio (Ratio de liquidité réduite)
2-point trend, +10.3%
3.4

Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans

Métrique
Tendance sur 5 ans
GRAL
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
4-point trend, +164.9%
17.2%
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
4-point trend, +164.9%
38.4%

Indicateurs par action BPA, valeur comptable par action, flux de trésorerie par action, dividende par action

Métrique
Tendance sur 5 ans
GRAL
Médiane des pairs
EPS (Diluted) (BPA (Dilué))
4-point trend, +93.6%
$-11.11

Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances

Métrique
Tendance sur 5 ans
GRAL
Médiane des pairs

GRAL Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse

ACHAT 15 analystes
  • Achat fort 4 26,7%
  • Achat 5 33,3%
  • Conserver 6 40,0%
  • Vente 0 0,0%
  • Vente forte 0 0,0%

Objectif de cours à 12 mois

8 analystes · 2026-08-19
Objectif médian $74.50 +3,0%
Objectif moyen $72.38 +0,1%

Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats

Surprise Moyenne
0.61%
Période EPS Actual BPA est. Surprise
30 juin 2026 $-2.56 $-2.71 0.15%
31 mars 2026 $-2.29 $-2.82 0.53%
31 décembre 2025 $-2.44 $-2.76 0.32%
30 septembre 2025 $-2.46 $-3.59 1.1%
30 juin 2025 $-3.18 $-3.64 0.46%
31 mars 2025 $-3.10 $-4.17 1.1%

Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur

Ticker Capitalisation Boursière P/E Revenus Année/Année Marge Nette ROE Marge Brute
GRAL $3.45B -7.7 17.2% -277.5% -16.7%
RCUS $2.99B -7.2 -4.3% -142.9% -59.8%
VCYT $3.34B 51.3 16.0% 12.8% 5.2% 70.1%
IDYA $3.04B -27.0 3024.4% -52.0% -11.5%
CLDX $1.81B -7.0 -78.0% -16748.0% -43.8%
ARQT $3.58B -223.4 91.3% -4.3% -9.8%
IOVA $1.12B -2.5 60.6% -148.4% -56.0%
IMNM $2.43B -8.8 -23.2% -3060.0% -47.0%
IRON $3.01B -13.2 -31.3%
NRIX $1.80B -5.8 53.9% -314.9% -53.6%

Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie

Compte de résultat 15
Données annuelles Compte de résultat pour GRAL
Métrique Tendance 202520242023
Revenue 3-point trend, +58.1% $147M $126M $93M
R&D Expense 3-point trend, -42.2% $196M $322M $339M
SG&A Expense 3-point trend, -20.6% $159M $214M $200M
Operating Expenses 3-point trend, -55.9% $709M $2.31B $1.61B
Operating Income 3-point trend, +62.9% $-562M $-2.19B $-1.52B
Interest Income 3-point trend, +260.2% $29M $27M $8M
Other Non-op 3-point trend, -377.4% $-993.0K $64.0K $-208.0K
Pretax Income 3-point trend, +64.5% $-535M $-2.16B $-1.51B
Income Tax 3-point trend, -200.7% $-126M $-135M $-42M
Net Income 3-point trend, +72.1% $-408M $-2.03B $-1.47B
EPS (Basic) 3-point trend, +76.5% $-11.11 $-63.54 $-47.21
EPS (Diluted) 3-point trend, +76.5% $-11.11 $-63.54 $-47.21
Shares (Basic) 3-point trend, +18.4% 36,753,751 31,901,259 31,049,148
Shares (Diluted) 3-point trend, +18.4% 36,753,751 31,901,259 31,049,148
EBITDA 2-point trend, +74.3% $-562M $-2.19B ·
Bilan 25
Données annuelles Bilan pour GRAL
Métrique Tendance 202520242023
Cash & Equivalents 3-point trend, +156.7% $250M $214M $97M
Receivables 3-point trend, +8.0% $18M $20M $17M
Prepaid Expense 3-point trend, -25.0% $15M $17M $20M
Current Assets 3-point trend, +511.2% $954M $820M $156M
PP&E (Net) 3-point trend, -39.0% $52M $69M $85M
PP&E (Gross) 3-point trend, +1.4% $122M $123M $121M
Accum. Depreciation 3-point trend, +98.2% $70M $54M $36M
Goodwill 2-point trend, -100.0% · $0 $889M
Intangibles 3-point trend, -31.1% $1.85B $2.02B $2.69B
Other Non-current Assets 3-point trend, -15.4% $7M $8M $8M
Total Assets 3-point trend, -25.3% $2.92B $2.98B $3.91B
Accounts Payable 3-point trend, -89.4% $2M $5M $20M
Accrued Liabilities 3-point trend, -13.4% $64M $57M $74M
Current Liabilities 3-point trend, -51.3% $80M $77M $164M
Capital Leases 3-point trend, -38.0% $43M $55M $70M
Deferred Tax 3-point trend, +564.0% $219M $346M $33M
Other Non-current Liabilities 3-point trend, +83.7% $3M $2M $1M
Total Liabilities 3-point trend, +28.6% $344M $480M $268M
Common Stock 2-point trend, +17.6% $40.0K $34.0K ·
Paid-in Capital 2-point trend, +3.9% $12.79B $12.31B ·
Retained Earnings 3-point trend, -31.3% $-10.21B $-9.80B $-7.78B
AOCI 3-point trend, +149.1% $3M $1M $1M
Stockholders' Equity 2-point trend, +3.0% $2.58B $2.50B ·
Liabilities + Equity 3-point trend, -25.3% $2.92B $2.98B $3.91B
Shares Outstanding 3-point trend, +40331360.00 40,331,360 33,893,409,000 0
Flux de trésorerie 10
Données annuelles Flux de trésorerie pour GRAL
Métrique Tendance 202520242023
Stock-based Comp 3-point trend, -40.1% $58M $86M $97M
Deferred Tax 3-point trend, -230.7% $-126M $-134M $-38M
Amort. of Intangibles Flat — no change across 3 periods $134M $134M $134M
Operating Cash Flow 3-point trend, +49.8% $-299M $-577M $-596M
CapEx 3-point trend, -92.9% $909.0K $5M $13M
Investing Cash Flow 3-point trend, -560.0% $-85M $-551M $-13M
Financing Cash Flow 3-point trend, -8.7% $423M $1.24B $464M
Net Change in Cash 3-point trend, +127.0% $39M $116M $-145M
Taxes Paid $1M · ·
Free Cash Flow 2-point trend, +48.5% $-300M $-582M ·
Rentabilité 7
Données annuelles Rentabilité pour GRAL
Métrique Tendance 202520242023
Operating Margin 2-point trend, +78.1% -382.0% -1743.0% ·
Net Margin 2-point trend, +82.8% -277.5% -1613.9% ·
Pretax Margin 2-point trend, +78.9% -363.2% -1721.7% ·
EBITDA Margin 2-point trend, +78.1% -382.0% -1743.0% ·
ROA 2-point trend, +76.5% -13.8% -58.8% ·
ROE 2-point trend, +79.0% -16.7% -79.6% ·
ROIC 2-point trend, +79.7% -16.7% -82.0% ·
Liquidité et Solvabilité 2
Données annuelles Liquidité et Solvabilité pour GRAL
Métrique Tendance 202520242023
Current Ratio 2-point trend, +12.3% 12.0 10.7 ·
Quick Ratio 2-point trend, +10.3% 3.4 3.0 ·
Efficacité 2
Données annuelles Efficacité pour GRAL
Métrique Tendance 202520242023
Asset Turnover 2-point trend, +36.8% 0.0 0.0 ·
Receivables Turnover 2-point trend, +13.1% 7.6 6.7 ·
Par action 5
Données annuelles Par action pour GRAL
Métrique Tendance 202520242023
Book Value / Share 2-point trend, -13.5% $63.92 $73.86 ·
Revenue / Share 2-point trend, +1.7% $4.00 $3.94 ·
Cash Flow / Share 2-point trend, +55.0% $-8.14 $-18.09 ·
Cash / Share 2-point trend, -2.0% $6.19 $6.32 ·
EPS (TTM) 2-point trend, +82.5% $-11.11 $-63.54 ·
Taux de croissance 2
Données annuelles Taux de croissance pour GRAL
Métrique Tendance 202520242023
Revenue YoY 3-point trend, -74.6% 17.2% 34.9% 67.6%
Revenue CAGR 3Y 38.4% · ·
Valorisation (TTM) 10
Données annuelles Valorisation (TTM) pour GRAL
Métrique Tendance 202520242023
Revenue TTM 2-point trend, +17.2% $147M $126M ·
Net Income TTM 2-point trend, +79.9% $-408M $-2.03B ·
Market Cap 2-point trend, +470.6% $3.45B $605M ·
P/E 2-point trend, -2642.6% -7.7 -0.3 ·
P/S 2-point trend, +386.9% 23.5 4.8 ·
P/B 2-point trend, +454.0% 1.3 0.2 ·
P / Tangible Book 2-point trend, +281.7% 4.7 1.2 ·
P / Cash Flow 2-point trend, -1001.4% -11.5 -1.0 ·
P / FCF 2-point trend, -1007.9% -11.5 -1.0 ·
Earnings Yield 2-point trend, +96.4% -13.0% -356.0% ·

États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années

Compte de résultat
2025-12-312024-12-312023-12-312023-01-01
Revenu $147M$126M$93M$56M
Marge d'exploitation % -382.0%-1743.0%
Résultat net $-408M$-2.03B$-1.47B$-5.40B
BPA dilué $-11.11$-63.54$-47.21$-173.89
Bilan
2025-12-312024-12-312023-12-312023-01-01
Ratio de liquidité 12.010.7
Ratio de liquidité réduite 3.43.0
Flux de trésorerie
2025-12-312024-12-312023-12-312023-01-01
Flux de trésorerie libre $-300M$-582M

Dernières actualités Actualités récentes mentionnant cette entreprise

Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets

📊

Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.

Votre sélection est enregistrée et vous suit sur tous les tickers.

Détenteurs institutionnels (13F) 411 déclarants · $2.2B total · Au 30 juin 2026

Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.

Activité institutionnelle — Q2 2026 vs trimestre précédent
Nouvelles positions Positions clôturées Augmenté Diminué Variation nette des actions
67 (+16 vs T. préc.) 45 (-49 vs T. préc.) 106 (+8 vs T. préc.) 102 (-12 vs T. préc.) +6.7M

Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.

Institution Valeur Actions % de 13F suivies Type
FARALLON CAPITAL MANAGEMENT, L.L.C. $284 111 340 4 161 584 13,20% Actions
BAKER BROS. ADVISORS LP $275 033 478 4 028 614 12,78% Actions
STATE STREET CORP $162 859 041 2 385 514 7,57% Actions
PRIMECAP MANAGEMENT CO/CA/ $148 835 838 2 180 106 6,91% Actions
Sessa Capital IM, L.P. $139 101 354 2 037 518 6,46% Actions
Deep Track Capital, LP $125 271 627 1 834 944 5,82% Actions
VANGUARD CAPITAL MANAGEMENT LLC $112 039 058 1 641 117 5,21% Actions
Arbiter Partners Capital Management LLC $70 611 456 1 034 297 3,28% Actions
GEODE CAPITAL MANAGEMENT, LLC $58 460 697 856 182 2,72% Actions
Jefferies Financial Group Inc. $49 427 480 724 000 2,30% Actions
Jefferies Financial Group Inc. $44 375 500 650 000 2,06% Option de vente
DIMENSIONAL FUND ADVISORS LP $43 707 751 640 219 2,03% Actions
GOLDMAN SACHS GROUP INC $42 579 111 623 687 1,98% Actions
BANK OF AMERICA CORP /DE/ $42 152 219 617 434 1,96% Actions
Casdin Capital, LLC $32 769 600 480 000 1,52% Actions
VANGUARD PORTFOLIO MANAGEMENT LLC $32 631 831 477 982 1,52% Actions
SUSQUEHANNA INTERNATIONAL GROUP, LLP $25 396 440 372 000 1,18% Option d'achat
SUSQUEHANNA INTERNATIONAL GROUP, LLP $24 563 546 359 800 1,14% Option de vente
KINGDON CAPITAL MANAGEMENT, L.L.C. $23 211 800 340 000 1,08% Actions
Granahan Investment Management, LLC $21 926 686 321 176 1,02% Actions
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $20 523 874 300 628 0,95% Actions
Aberdeen Group plc $15 668 170 229 503 0,73% Actions
VANGUARD FIDUCIARY TRUST CO $15 357 337 224 950 0,71% Actions
Slow Capital, Inc. $14 832 477 217 262 0,69% Actions
CITADEL ADVISORS LLC $14 616 607 214 100 0,68% Option d'achat
TCW GROUP INC $13 101 901 191 913 0,61% Actions
Douglas Lane & Associates, LLC $11 082 952 162 340 0,51% Actions
SUSQUEHANNA INTERNATIONAL GROUP, LLP $10 601 990 155 295 0,49% Actions
RAYMOND JAMES FINANCIAL INC $10 495 215 153 731 0,49% Actions
Newtyn Management, LLC $10 240 500 150 000 0,48% Actions
180 WEALTH ADVISORS, LLC $8 723 113 127 774 0,41% Actions
Voleon Capital Management LP $8 264 903 121 062 0,38% Actions
FMR LLC $8 139 559 119 226 0,38% Actions
WIM INVESTMENT MANAGEMENT Ltd $7 263 928 106 400 0,34% Actions
Alyeska Investment Group, L.P. $7 168 350 105 000 0,33% Actions
AMERICAN CENTURY COMPANIES INC $6 774 228 99 227 0,31% Actions
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $5 809 000 85 089 0,27% Actions
Swiss National Bank $5 202 174 76 200 0,24% Actions
Susquehanna Portfolio Strategies, LLC $4 853 178 71 088 0,23% Actions
NATIXIS $4 794 329 70 226 0,22% Actions
CITADEL ADVISORS LLC $4 601 398 67 400 0,21% Option de vente
BARCLAYS PLC $4 557 091 66 751 0,21% Actions
GAMCO INVESTORS, INC. ET AL $4 554 497 66 713 0,21% Actions
D. E. Shaw & Co., Inc. $4 444 787 65 106 0,21% Actions
JACOBS LEVY EQUITY MANAGEMENT, INC $3 810 968 55 822 0,18% Actions
Allianz Asset Management GmbH $3 810 695 55 818 0,18% Actions
JANE STREET GROUP, LLC $3 775 331 55 300 0,18% Option d'achat
RHUMBLINE ADVISERS $3 773 202 55 269 0,18% Actions
Public Sector Pension Investment Board $3 633 534 53 223 0,17% Actions
Pictet Asset Management Holding SA $3 421 492 50 039 0,16% Actions
Centiva Capital, LP $3 413 500 50 000 0,16% Option d'achat
Verition Fund Management LLC $3 334 921 48 849 0,15% Actions
BlackRock, Inc. $3 131 886 45 875 0,15% Actions
BNP PARIBAS FINANCIAL MARKETS $3 072 150 450 0,14% Option d'achat
D. E. Shaw & Co., Inc. $3 072 150 45 000 0,14% Option de vente
Legal Advantage Investments, Inc. $3 046 549 44 625 0,14% Actions
HighTower Advisors, LLC $2 769 342 40 565 0,13% Actions
Rafferty Asset Management, LLC $2 697 962 39 519 0,13% Actions
Timelo Investment Management Inc. $2 662 530 39 000 0,12% Actions
ALLIANCEBERNSTEIN L.P. $2 492 320 48 226 0,12% Actions
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $2 298 210 44 470 0,11% Actions
Lido Advisors, LLC $2 270 250 33 254 0,11% Actions
BNP PARIBAS FINANCIAL MARKETS $2 252 910 330 0,10% Option de vente
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $2 211 768 30 719 0,10% Actions
BNP PARIBAS FINANCIAL MARKETS $2 133 984 31 258 0,10% Actions
Summit Financial, LLC $2 103 877 30 817 0,10% Actions
GABELLI FUNDS LLC $2 067 420 30 283 0,10% Actions
JONES FINANCIAL COMPANIES LLLP $1 988 740 30 169 0,09% Actions
OSAIC HOLDINGS, INC. $1 906 981 27 934 0,09% Actions
TWO SIGMA INVESTMENTS, LP $1 872 305 27 425 0,09% Actions
COMMERCE BANK $1 841 993 26 981 0,09% Actions
UBS Group AG $1 835 234 26 882 0,09% Actions
Concurrent Investment Advisors, LLC $1 833 850 26 862 0,09% Actions
Gem Investment Advisors, LLC $1 828 339 26 781 0,08% Actions
VANGUARD ASSET MANAGEMENT, Ltd $1 823 765 26 714 0,08% Actions
Legato Capital Management LLC $1 804 649 26 434 0,08% Actions
PVG ASSET MANAGEMENT CORP $1 767 305 25 887 0,08% Actions
CANADA PENSION PLAN INVESTMENT BOARD $1 761 366 25 800 0,08% Actions
IMC-Chicago, LLC $1 710 368 25 053 0,08% Actions
Jackson Hole Capital Partners, LLC $1 705 440 33 000 0,08% Actions
Sheets Smith Investment Management $1 688 635 28 558 0,08% Actions
MetLife Investment Management, LLC $1 649 813 24 166 0,08% Actions
Gotham Asset Management, LLC $1 634 384 23 940 0,08% Actions
Quantinno Capital Management LP $1 593 922 23 347 0,07% Actions
TWO SIGMA ADVISERS, LP $1 592 060 18 601 0,07% Actions
CLOUGH CAPITAL PARTNERS L P $1 566 387 22 944 0,07% Actions
STATE OF WISCONSIN INVESTMENT BOARD $1 522 353 22 299 0,07% Actions
MANUFACTURERS LIFE INSURANCE COMPANY, THE $1 474 427 21 597 0,07% Actions
LPL Financial LLC $1 393 254 20 408 0,06% Actions
PROFUND ADVISORS LLC $1 370 725 20 078 0,06% Actions
Perigon Wealth Management, LLC $1 348 537 19 753 0,06% Actions
Zurcher Kantonalbank (Zurich Cantonalbank) $1 271 324 18 622 0,06% Actions
Invesco Ltd. $1 117 853 16 374 0,05% Actions
Bouvel Investment Partners, LLC $1 106 998 16 215 0,05% Actions
AMERIPRISE FINANCIAL INC $1 082 216 15 852 0,05% Actions
NORGES BANK $1 077 983 15 790 0,05% Actions
EXCHANGE TRADED CONCEPTS, LLC $1 054 703 15 449 0,05% Actions
STRS OHIO $1 044 531 15 300 0,05% Actions
PRUDENTIAL FINANCIAL INC $1 006 300 14 740 0,05% Actions
NEW YORK STATE COMMON RETIREMENT FUND $996 469 14 596 0,05% Actions

Initiés de la société 8 initiés · 2 dirigeants · 5 administrateurs

Dirigeant Rôle Dernière activité Actions détenues Achats 12m Ventes 12m Net 12m
Joshua J. Ofman Chief Executive Officer 1 juin 2026 A 402 271 0 0 $0
Andrew John Partridge Chief Growth Officer 4 juin 2026 S 163 738 0 1 $-91 070
William J Chase Administrateur 15 juillet 2026 A 42 978 0 0 $0
Steven Mizell Administrateur 15 juillet 2026 A 42 830 0 0 $0
Gregory L Summe Administrateur 15 juillet 2026 A 45 672 0 0 $0
Sarah Krevans Administrateur 18 juin 2026 A 42 628 0 0 $0
ILLUMINA, INC. Détenteur de 10% 17 novembre 2025 S 3 502 126 0 1 $-79 850 000
Chun R Ding Détenteur de 10% 9 octobre 2024 P 3 644 855 0 0 $0

Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché

Détention d'ETF Détenu par 50 ETFs

Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.

Fonds Poids Unités Au Source
HTEC · EXCHANGE TRADED CONCEPTS TRUST 1,90% 18 597 NS 30 avril 2026 N-PORT
LABU · Direxion Shares ETF Trust 0,63% 59 651 NS 30 avril 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,21% 87 481 SH 8 août 2026 Quotidien
IBBQ · Invesco Exchange-Traded Fund Trust … 0,20% 2 336 SH 8 août 2026 Quotidien
IBB · iShares Trust 0,19% 291 644 SH 8 août 2026 Quotidien
VTWV · VANGUARD SCOTTSDALE FUNDS 0,18% 36 116 SH 8 août 2026 Quotidien
AVSC · AMERICAN CENTURY ETF TRUST 0,17% 67 501 NS 31 mai 2026 N-PORT
IWN · iShares Trust 0,17% 385 837 SH 8 août 2026 Quotidien
ESSC · Strategy Shares 0,15% 712 NS 30 avril 2026 N-PORT
BIB · ProShares Trust 0,14% 1 439 NS 31 mai 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,09% 237 749 SH 8 août 2026 Quotidien
IWM · iShares Trust 0,08% 1 053 632 SH 8 août 2026 Quotidien
GSSC · Goldman Sachs ETF Trust 0,08% 11 051 NS 31 mai 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0,08% 1 185 NS 30 avril 2026 N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,07% 9 665 NS 30 avril 2026 N-PORT
ITWO · ProShares Trust 0,06% 1 654 NS 31 mai 2026 N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe… 0,06% 2 459 SH 8 août 2026 Quotidien
RSSL · Global X Funds 0,06% 15 208 NS 30 avril 2026 N-PORT
ESML · iShares Trust 0,05% 22 118 SH 8 août 2026 Quotidien
DFAS · Dimensional ETF Trust 0,05% 117 357 NS 30 avril 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,05% 143 168 NS 31 mai 2026 N-PORT
ISCG · iShares Trust 0,04% 6 428 SH 8 août 2026 Quotidien
VHT · VANGUARD WORLD FUND 0,04% 114 187 SH 8 août 2026 Quotidien
UWM · ProShares Trust 0,04% 1 294 NS 31 mai 2026 N-PORT
ISCB · iShares Trust 0,04% 1 688 SH 8 août 2026 Quotidien
ISCV · iShares Trust 0,04% 3 927 SH 8 août 2026 Quotidien
SMLF · iShares Trust 0,03% 20 757 SH 8 août 2026 Quotidien
FHLC · FIDELITY COVINGTON TRUST 0,03% 16 096 NS 30 avril 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,03% 374 291 SH 8 août 2026 Quotidien
URTY · ProShares Trust 0,03% 1 307 NS 31 mai 2026 N-PORT
WSML · iShares Trust 0,02% 2 078 SH 8 août 2026 Quotidien
DXUV · Dimensional ETF Trust 0,02% 1 178 NS 30 avril 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,01% 1 399 NS 31 mai 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0,01% 23 351 NS 31 mai 2026 N-PORT
HDG · ProShares Trust 0,01% 33 NS 31 mai 2026 N-PORT
DCOR · Dimensional ETF Trust 0,01% 4 910 NS 30 avril 2026 N-PORT
ONEQ · Fidelity Commonwealth Trust 0,01% 11 015 NS 31 mai 2026 N-PORT
DFAC · Dimensional ETF Trust 0,01% 51 657 NS 30 avril 2026 N-PORT
IWV · iShares Trust 0,00% 11 704 SH 8 août 2026 Quotidien
IETC · iShares U.S. ETF Trust 0,00% 375 SH 8 août 2026 Quotidien
ACVF · ETF Opportunities Trust 0,00% 82 NS 30 avril 2026 N-PORT
ITOT · iShares Trust 0,00% 45 817 SH 8 août 2026 Quotidien
AVSU · AMERICAN CENTURY ETF TRUST 0,00% 192 NS 31 mai 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0,00% 17 955 NS 31 mai 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 9 362 NS 30 avril 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 4 660 NS 30 avril 2026 N-PORT
DFUV · Dimensional ETF Trust 0,00% 3 550 NS 30 avril 2026 N-PORT
DFLV · Dimensional ETF Trust 0,00% 321 NS 30 avril 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,00% 1 228 926 SH 8 août 2026 Quotidien
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 3 407 SH 8 août 2026 Quotidien